Patch, you should look at it closer. They are flush with cash. I know you like trading, so I am sure you are buying this. Longer term may prove fruitful. JMO
Could be class 1 or 2, King didn't know with device. Looks like they can address these questions and move forward. This may be a good add point for those who are patient. Class 1 is 2 month review and class 2 is 6 months as you know. No questions or need for clinical, so I stand firm in my position. Best to you!!
Cheers, what happens to the hats of the losing team for Super Bowl. Fire pit. Maybe those are worth a lot like a double struck buffalo nickel (Ie the ones that aren't destroyed).
Did you see PTX yahoo estimates for EPS in 2015. $0.96, that would be nice start.
Thank you, now I will be on observation. I feel safe with folks like you checking the nimwits. Stilldung is nearing most usefulness as combustion material.
Why don't You be a little more specific, maybe you should publish a book on this? Gogs might buy it if you sign it.
Not really, you all are doing fine work, so I can watch. Best to all longs!! Let the bashers waste time typing dum-dum scary posts instead of typing out covering orders.
Maybe Perceptive will have to add if it gets cheaper. May take a while and FRX got bought out, is this correct, Frederick? Then who knows if new concern of FRX will stay with it, JMO. Perceptive doing well in ACRX, big day soon.
Maybe PTX can sell IPCI drugs for them? IPCI lacks sales expertise.
True, yellen doesn't know small pharma. There are many good values compared to year Y2K era. Market caps are reasonable and merger mania will likely continue. I don't have GERN yet. Are you looking at IGXT? Saw a post on this.